Remdesivir had little or no effect on Covid-19 patient's hospital stay or survival: WHO trial


Content Team
Image Credit: Shortpedia

According to a clinical trial of Remdesivir - a medicine that was touted as a game-changer against Covid19 by many including Donald Trump, by WHO, the medicine did not cut the hospital stay period of coronavirus patients. No results were found in the trials to prove that Remdesivir helped in saving the lives of critical patients. The US Food and Drug Administration had okayed the emergency use of Remdesivir on May 1.